These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 4167698)

  • 1. Skeletal changes in murine runt disease.
    Simmons DJ; Simmons RL
    Am J Anat; 1967 Jul; 121(1):15-28. PubMed ID: 4167698
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic runt disease in rats: clinical and pathologic studies.
    Abe T; Shimada S; Osako R
    J Natl Cancer Inst; 1969 Aug; 43(2):459-67. PubMed ID: 4894673
    [No Abstract]   [Full Text] [Related]  

  • 3. Quantitative analysis of the chimaeric state in mice. II. Cytological examination of the proportion of proliferating donor and host cells in runt disease in mice.
    Nakić B; Kastelan A; Mikuska J; Bunarević A
    Immunology; 1967 Jun; 12(6):615-27. PubMed ID: 6027421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three forms of runt disease. A quantitative, morphologic study.
    Naeye RL
    Arch Pathol; 1969 Mar; 87(3):326-31. PubMed ID: 5766258
    [No Abstract]   [Full Text] [Related]  

  • 5. Transient graft-versus-host reaction in the treatment of leukemia in mice.
    Boranić M
    J Natl Cancer Inst; 1968 Aug; 41(2):421-37. PubMed ID: 4876445
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on runt disease in inbred mice. II. Discussion of the Simonsen criterion].
    Lemmel EM; Böhm F; Nouza K
    Z Immunitatsforsch Allerg Klin Immunol; 1968 Jan; 134(5):436-48. PubMed ID: 4233170
    [No Abstract]   [Full Text] [Related]  

  • 7. [Induction of histoimmune shock in the transplantation of heterologous splenic cells and bone marrow].
    Shevelev AS; Semenkov VF; Fedosov EA; Stysina EE; Fomina AA
    Biull Eksp Biol Med; 1966 Feb; 61(2):68-71. PubMed ID: 4882188
    [No Abstract]   [Full Text] [Related]  

  • 8. Breakdown of Friend virus-induced tolerance and development of runting syndrome in rats.
    Takeichi N; Kaji H; Kodama T; Kobayashi H
    Cancer Res; 1974 Mar; 34(3):543-50. PubMed ID: 4812261
    [No Abstract]   [Full Text] [Related]  

  • 9. Delayed mortality in sublethally irradiated mice treated with allogeneic lymphoid and myeloid cells.
    Boranić M
    J Natl Cancer Inst; 1968 Aug; 41(2):439-50. PubMed ID: 4876446
    [No Abstract]   [Full Text] [Related]  

  • 10. Reversal of post-thymectomy wasting disease in mice by multiple thymus grafts.
    Stutman O; Yunis EJ; Martinez C; Good RA
    J Immunol; 1967 Jan; 98(1):79-87. PubMed ID: 6018772
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experimental research on homografts, Tolerance and runt disease in Fischer rats].
    Visentini P; Mazzoleni F; Paladini E
    Acta Chir Ital; 1966; 22(4):369-72. PubMed ID: 4868150
    [No Abstract]   [Full Text] [Related]  

  • 12. Preventive effect of ultraviolet radiation on murine chronic sclerodermatous graft-versus-host disease.
    Mermet I; Kleinclauss F; Marandin A; Guérrini JS; Angonin R; Tiberghien P; Saas P; Aubin F
    Transplantation; 2007 Dec; 84(12):1696-700. PubMed ID: 18165783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biology of graft-versus-host reactions.
    Billingham RE
    Harvey Lect; 1966-1967; 62():21-78. PubMed ID: 4875305
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on immunologic unresponsiveness during secondary disease. II. The effect of added donor and host immunologically competent cells.
    Thompson JS; Simmons EL; Moy RH; Crawford MK
    J Immunol; 1967 Jan; 98(1):179-85. PubMed ID: 5335178
    [No Abstract]   [Full Text] [Related]  

  • 15. Tolerance manifestations among inbred rat strains defined in the Rt H-1 antigens. I. Runt syndrome incidence and skin graft tolerance.
    Kren V; Stark O; Krenová D
    Folia Biol (Krakow); 1969; 17(3):188-96. PubMed ID: 5801812
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of macrophage migration inhibitory factor (MIF) on acute graft-versus-host disease in a murine model of allogeneic stem cell transplantation.
    Toubai T; Tanaka J; Nishihira J; Ohkawara T; Hirate D; Kondo N; Tone S; Shono Y; Ibata M; Sugita J; Kato N; Miura Y; Iwao N; Ota S; Imamura M
    Transpl Immunol; 2006 Aug; 16(2):117-24. PubMed ID: 16860715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malononitrilamides inhibit the development of various murine graft-vs-host diseases.
    Schorlemmer HU; Kurrle R; Bartlett RR
    Transplant Proc; 1996 Dec; 28(6):3043-7. PubMed ID: 8962181
    [No Abstract]   [Full Text] [Related]  

  • 18. Some effects of Escherichia coli endotoxin on the graft-versus-host reaction in mice.
    Skopińska E
    Transplantation; 1972 Oct; 14(4):432-7. PubMed ID: 4404954
    [No Abstract]   [Full Text] [Related]  

  • 19. Erythrokinetic effect of parental spleen cells in hybrid mice.
    Bain GO
    Arch Pathol; 1965 Oct; 80(4):397-408. PubMed ID: 5836482
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical and pathologic characteristics of graft-versus-host disease produced in cyclophosphamide-treated adult mice.
    Sandberg JS; Owens AH; Santos GW
    J Natl Cancer Inst; 1971 Jan; 46(1):151-60. PubMed ID: 4395991
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.